Debora Ferguson
Psychiatry · Bloomfield Hills, MINPI 1902812100
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 617 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Lundbeck LLC at 28.4% of the total. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 617 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$3K
- Sunovion Pharmaceuticals Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Corium, LLC$739
- Alkermes, Inc.$599
- plus $2K from 16 others
What the payments were for
- Food & beverage$11,518100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 194 | $3,274 |
| Sunovion Pharmaceuticals Inc. | 125 | $2,192 |
| Otsuka America Pharmaceutical, Inc. | 76 | $1,739 |
| Takeda Pharmaceuticals U.S.A., Inc. | 75 | $1,113 |
| Corium, LLC | 43 | $739 |
| Alkermes, Inc. | 24 | $599 |
| Axsome Therapeutics, Inc. | 11 | $290 |
| Supernus Pharmaceuticals, Inc. | 9 | $268 |
| Shire North American Group Inc | 12 | $231 |
| Ironshore Pharmaceuticals Inc. | 11 | $223 |
| Vanda Pharmaceuticals Inc. | 10 | $167 |
| Neuronetics, Inc. | 1 | $120 |
| Lilly USA, LLC | 1 | $100 |
| Tris Pharma Inc | 4 | $85 |
| Arbor Pharmaceuticals, Inc. | 4 | $73 |
| Vertical Pharmaceuticals, LLC | 3 | $67 |
| Johnson & Johnson | 5 | $55 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $54 |
| Idorsia Pharmaceuticals US Inc | 2 | $47 |
| OWP Pharmaceuticals, Inc. | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 1 | $27 |
| Neos Therapeutics, LP | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$629
- QELBREE$125
- LATUDA$125
- Auvelity$121
- NEUROSTAR TMS THERAPY$120
How this compares
$11,518 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 73 | $107,429 |
| TrintellixVortioxetine Hydrobromide | 30 | $15,995 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 243 | $6,297 |
| Alprazolam | 313 | $4,059 |
| Duloxetine Hcl | 160 | $4,033 |
| Clonazepam | 151 | $4,024 |
| Fluvoxamine Maleate | 41 | $3,535 |
| Lurasidone Hcl | 34 | $2,356 |
| Methylphenidate Hcl | 54 | $2,328 |
| Lamotrigine | 120 | $1,972 |
| Atomoxetine Hcl | 23 | $1,823 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $1,723 |
| Aripiprazole | 86 | $1,582 |
| Quetiapine Fumarate | 123 | $1,540 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 61 | $1,501 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,739 | $107,42973 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,113 | $15,99530 claims |
| Lilly USA, LLCOlanzapine | $100 | $74545 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Bloomfield Hills
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
- Theodore RuzaWest Bloomfield$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.